Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction

AimTo evaluate the impact of preinterventional moderate-to-severe functional tricuspid regurgitation (FTR) on early outcome after percutaneous edge-to-edge mitral valve repair (pMVR) with MitraClip procedures for functional mitral regurgitation (FMR) in patients with heart failure with reduced eject...

Full description

Bibliographic Details
Main Authors: Takayuki Gyoten, Daniel Messroghli, Soeren Schenk, Kristin Rochor, Oliver Grimmig, Soeren Just, Dirk Fritzsche
Format: Article
Language:English
Published: BMJ Publishing Group 2020-06-01
Series:Open Heart
Online Access:https://openheart.bmj.com/content/7/1/e001203.full
_version_ 1818435627922751488
author Takayuki Gyoten
Daniel Messroghli
Soeren Schenk
Kristin Rochor
Oliver Grimmig
Soeren Just
Dirk Fritzsche
author_facet Takayuki Gyoten
Daniel Messroghli
Soeren Schenk
Kristin Rochor
Oliver Grimmig
Soeren Just
Dirk Fritzsche
author_sort Takayuki Gyoten
collection DOAJ
description AimTo evaluate the impact of preinterventional moderate-to-severe functional tricuspid regurgitation (FTR) on early outcome after percutaneous edge-to-edge mitral valve repair (pMVR) with MitraClip procedures for functional mitral regurgitation (FMR) in patients with heart failure with reduced ejection fraction (HFrEF).Methods and resultsFrom January 2013 to December 2017, 80 patients with HFrEF (ejection fraction 22%±5.3%) and FMR (grade 3.0±0.36) underwent successful pMVR. The 3-year actuarial survival was 58%. However, 73% (n=22) of non-survivors died of cardiac failure within 1 year. Patients were categorised into none-to-mild (n=36) and moderate-to-severe (n=44) postinterventional FTR groups according to pre-MitraClip tricuspid regurgitation grade. Cox regression analysis on 1-year survival demonstrated an impact of FTR severity (HR=1.8, 95% CI 1.01% to 3.09%, p=0.047), preoperative New York Heart Association class (HR=2.8, 95% CI 1.2% to 6.5%, p=0.015) and peripheral artery disease (HR=5.4, 95% CI 1.6 to 18, p=0.0054). Kaplan-Meier analysis showed that 1-year cardiac death was higher in the moderate-to-severe FTR group (p=0.048). In our study, 77% of pre-MitraClip moderate-to-severe FTR cannot be significantly reduced. Post-MitraClip moderate-to-severe FTR grade was related to lower survival (p<0.001).ConclusionIn patients with HFrEF treated with MitraClip for FMR, moderate-to-severe FTR was an independent predictor of cardiac death within 1 year. To improve survival, additional therapy to residual FTR should be considered in early phase after MitraClip therapy.
first_indexed 2024-12-14T16:55:54Z
format Article
id doaj.art-58a55fdd72734c2d840770703af1cc59
institution Directory Open Access Journal
issn 2053-3624
language English
last_indexed 2024-12-14T16:55:54Z
publishDate 2020-06-01
publisher BMJ Publishing Group
record_format Article
series Open Heart
spelling doaj.art-58a55fdd72734c2d840770703af1cc592022-12-21T22:53:58ZengBMJ Publishing GroupOpen Heart2053-36242020-06-017110.1136/openhrt-2019-001203Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fractionTakayuki Gyoten0Daniel Messroghli1Soeren Schenk2Kristin Rochor3Oliver Grimmig4Soeren Just5Dirk Fritzsche6Cardiac Surgery, Sana-Herzzentrum Cottbus, Cottbus, Brandenburg, GermanyCardiology, Deutsches Herzzentrum Berlin, Berlin, GermanyCardiac Surgery, Sana-Herzzentrum Cottbus, Cottbus, Brandenburg, GermanyCardiac Surgery, Sana-Herzzentrum Cottbus, Cottbus, Brandenburg, GermanyCardiac Surgery, Sana-Herzzentrum Cottbus, Cottbus, Brandenburg, GermanyCardiac Surgery, Sana-Herzzentrum Cottbus, Cottbus, Brandenburg, GermanyCardiac Surgery, Sana-Herzzentrum Cottbus, Cottbus, Brandenburg, GermanyAimTo evaluate the impact of preinterventional moderate-to-severe functional tricuspid regurgitation (FTR) on early outcome after percutaneous edge-to-edge mitral valve repair (pMVR) with MitraClip procedures for functional mitral regurgitation (FMR) in patients with heart failure with reduced ejection fraction (HFrEF).Methods and resultsFrom January 2013 to December 2017, 80 patients with HFrEF (ejection fraction 22%±5.3%) and FMR (grade 3.0±0.36) underwent successful pMVR. The 3-year actuarial survival was 58%. However, 73% (n=22) of non-survivors died of cardiac failure within 1 year. Patients were categorised into none-to-mild (n=36) and moderate-to-severe (n=44) postinterventional FTR groups according to pre-MitraClip tricuspid regurgitation grade. Cox regression analysis on 1-year survival demonstrated an impact of FTR severity (HR=1.8, 95% CI 1.01% to 3.09%, p=0.047), preoperative New York Heart Association class (HR=2.8, 95% CI 1.2% to 6.5%, p=0.015) and peripheral artery disease (HR=5.4, 95% CI 1.6 to 18, p=0.0054). Kaplan-Meier analysis showed that 1-year cardiac death was higher in the moderate-to-severe FTR group (p=0.048). In our study, 77% of pre-MitraClip moderate-to-severe FTR cannot be significantly reduced. Post-MitraClip moderate-to-severe FTR grade was related to lower survival (p<0.001).ConclusionIn patients with HFrEF treated with MitraClip for FMR, moderate-to-severe FTR was an independent predictor of cardiac death within 1 year. To improve survival, additional therapy to residual FTR should be considered in early phase after MitraClip therapy.https://openheart.bmj.com/content/7/1/e001203.full
spellingShingle Takayuki Gyoten
Daniel Messroghli
Soeren Schenk
Kristin Rochor
Oliver Grimmig
Soeren Just
Dirk Fritzsche
Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction
Open Heart
title Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction
title_full Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction
title_fullStr Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction
title_full_unstemmed Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction
title_short Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction
title_sort impact of preinterventional tricuspid regurgitation on outcome of mitraclip therapy in patients with severely reduced ejection fraction
url https://openheart.bmj.com/content/7/1/e001203.full
work_keys_str_mv AT takayukigyoten impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction
AT danielmessroghli impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction
AT soerenschenk impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction
AT kristinrochor impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction
AT olivergrimmig impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction
AT soerenjust impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction
AT dirkfritzsche impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction